Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Influenza

  Free Subscription


Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 127 articles:
HTML format



Single Articles


    July 2020
  1. YAO Y, Kadam RU, Lee CD, Woehl JL, et al
    An influenza A hemagglutinin small-molecule fusion inhibitor identified by a new high-throughput fluorescence polarization screen.
    Proc Natl Acad Sci U S A. 2020 Jul 20. pii: 2006893117.
    PubMed     Abstract available


  2. LIAO HY, Wang SC, Ko YA, Lin KI, et al
    Chimeric hemagglutinin vaccine elicits broadly protective CD4 and CD8 T cell responses against multiple influenza strains and subtypes.
    Proc Natl Acad Sci U S A. 2020 Jul 15. pii: 2004783117.
    PubMed     Abstract available


  3. SIEGENFELD AF, Taleb NN, Bar-Yam Y
    Opinion: What models can and cannot tell us about COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:16092-16095.
    PubMed    


  4. LAMMERS J, Crusius J, Gast A
    Correcting misperceptions of exponential coronavirus growth increases support for social distancing.
    Proc Natl Acad Sci U S A. 2020;117:16264-16266.
    PubMed     Abstract available


  5. ESTEVE A, Permanyer I, Boertien D, Vaupel JW, et al
    National age and coresidence patterns shape COVID-19 vulnerability.
    Proc Natl Acad Sci U S A. 2020;117:16118-16120.
    PubMed     Abstract available


  6. IMAI M, Iwatsuki-Horimoto K, Hatta M, Loeber S, et al
    Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development.
    Proc Natl Acad Sci U S A. 2020;117:16587-16595.
    PubMed     Abstract available


  7. ELLEBEDY AH, Nachbagauer R, Jackson KJL, Dai YN, et al
    Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans.
    Proc Natl Acad Sci U S A. 2020 Jul 13. pii: 1906613117.
    PubMed     Abstract available


  8. BONACCORSI G, Pierri F, Cinelli M, Flori A, et al
    Economic and social consequences of human mobility restrictions under COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:15530-15535.
    PubMed     Abstract available


  9. MALISCH JL, Harris BN, Sherrer SM, Lewis KA, et al
    Opinion: In the wake of COVID-19, academia needs new solutions to ensure gender equity.
    Proc Natl Acad Sci U S A. 2020;117:15378-15381.
    PubMed    


  10. AREVALO CP, Le Sage V, Bolton MJ, Eilola T, et al
    Original antigenic sin priming of influenza virus hemagglutinin stalk antibodies.
    Proc Natl Acad Sci U S A. 2020 Jul 6. pii: 1920321117.
    PubMed     Abstract available


  11. MULLER NF, Stolz U, Dudas G, Stadler T, et al
    Bayesian inference of reassortment networks reveals fitness benefits of reassortment in human influenza viruses.
    Proc Natl Acad Sci U S A. 2020 Jul 6. pii: 1918304117.
    PubMed     Abstract available


    June 2020
  12. ZHANG R, Li Y, Zhang AL, Wang Y, et al
    Identifying airborne transmission as the dominant route for the spread of COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:14857-14863.
    PubMed     Abstract available


  13. BENZELL SG, Collis A, Nicolaides C
    Rationing social contact during the COVID-19 pandemic: Transmission risk and social benefits of US locations.
    Proc Natl Acad Sci U S A. 2020;117:14642-14644.
    PubMed     Abstract available


  14. SUN H, Xiao Y, Liu J, Wang D, et al
    Prevalent Eurasian avian-like H1N1 swine influenza virus with 2009 pandemic viral genes facilitating human infection.
    Proc Natl Acad Sci U S A. 2020 Jun 29. pii: 1921186117.
    PubMed     Abstract available


  15. SCHREIBER A, Boff L, Anhlan D, Krischuns T, et al
    Dissecting the mechanism of signaling-triggered nuclear export of newly synthesized influenza virus ribonucleoprotein complexes.
    Proc Natl Acad Sci U S A. 2020 Jun 29. pii: 2002828117.
    PubMed     Abstract available


  16. DOWD JB, Andriano L, Brazel DM, Rotondi V, et al
    Reply to Nepomuceno et al.: A renewed call for detailed social and demographic COVID-19 data from all countries.
    Proc Natl Acad Sci U S A. 2020;117:13884-13885.
    PubMed    


  17. NEPOMUCENO MR, Acosta E, Alburez-Gutierrez D, Aburto JM, et al
    Besides population age structure, health and other demographic factors can contribute to understanding the COVID-19 burden.
    Proc Natl Acad Sci U S A. 2020;117:13881-13883.
    PubMed    


  18. WANG Y, Liu M, Gao J
    Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions.
    Proc Natl Acad Sci U S A. 2020;117:13967-13974.
    PubMed     Abstract available


  19. CEBALLOS G, Ehrlich PR, Raven PH
    Vertebrates on the brink as indicators of biological annihilation and the sixth mass extinction.
    Proc Natl Acad Sci U S A. 2020;117:13596-13602.
    PubMed     Abstract available


  20. FORSTER P, Forster L, Renfrew C, Forster M, et al
    Reply to Sanchez-Pacheco et al., Chookajorn, and Mavian et al.: Explaining phylogenetic network analysis of SARS-CoV-2 genomes.
    Proc Natl Acad Sci U S A. 2020;117:12524-12525.
    PubMed    


  21. RAKER EJ, Zacher M, Lowe SR
    Lessons from Hurricane Katrina for predicting the indirect health consequences of the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2020;117:12595-12597.
    PubMed     Abstract available


  22. ZENG F, Chen X, Deng G
    Convalescent plasma for patients with COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:12528.
    PubMed    


  23. KESICI S, Yavuz S, Bayrakci B
    Get rid of the bad first: Therapeutic plasma exchange with convalescent plasma for severe COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:12526-12527.
    PubMed    


  24. DUAN K, Liu B, Li C, Zhang H, et al
    Reply to Kesici et al. and Zeng et al.: Blocking the virus and reducing the inflammatory damage in COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:12529-12530.
    PubMed    


  25. CHOOKAJORN T
    Evolving COVID-19 conundrum and its impact.
    Proc Natl Acad Sci U S A. 2020;117:12520-12521.
    PubMed    


  26. MAVIAN C, Pond SK, Marini S, Magalis BR, et al
    Sampling bias and incorrect rooting make phylogenetic network tracing of SARS-COV-2 infections unreliable.
    Proc Natl Acad Sci U S A. 2020;117:12522-12523.
    PubMed    


  27. SANCHEZ-PACHECO SJ, Kong S, Pulido-Santacruz P, Murphy RW, et al
    Median-joining network analysis of SARS-CoV-2 genomes is neither phylogenetic nor evolutionary.
    Proc Natl Acad Sci U S A. 2020;117:12518-12519.
    PubMed    


  28. STADNYTSKYI V, Bax CE, Bax A, Anfinrud P, et al
    The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission.
    Proc Natl Acad Sci U S A. 2020;117:11875-11877.
    PubMed     Abstract available


    May 2020
  29. DELAVERIS CS, Webster ER, Banik SM, Boxer SG, et al
    Membrane-tethered mucin-like polypeptides sterically inhibit binding and slow fusion kinetics of influenza A virus.
    Proc Natl Acad Sci U S A. 2020 May 26. pii: 1921962117.
    PubMed     Abstract available


  30. BENTO AI, Nguyen T, Wing C, Lozano-Rojas F, et al
    Evidence from internet search data shows information-seeking responses to news of local COVID-19 cases.
    Proc Natl Acad Sci U S A. 2020;117:11220-11222.
    PubMed     Abstract available


  31. REILLY EC, Lambert Emo K, Buckley PM, Reilly NS, et al
    TRM integrins CD103 and CD49a differentially support adherence and motility after resolution of influenza virus infection.
    Proc Natl Acad Sci U S A. 2020 May 21. pii: 1915681117.
    PubMed     Abstract available


  32. XU X, Han M, Li T, Sun W, et al
    Effective treatment of severe COVID-19 patients with tocilizumab.
    Proc Natl Acad Sci U S A. 2020;117:10970-10975.
    PubMed     Abstract available


  33. GATTO M, Bertuzzo E, Mari L, Miccoli S, et al
    Spread and dynamics of the COVID-19 epidemic in Italy: Effects of emergency containment measures.
    Proc Natl Acad Sci U S A. 2020;117:10484-10491.
    PubMed     Abstract available


  34. DOWD JB, Andriano L, Brazel DM, Rotondi V, et al
    Demographic science aids in understanding the spread and fatality rates of COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:9696-9698.
    PubMed     Abstract available


  35. MCDERMOTT A
    Inner Workings: Molecular biologists offer "wartime service" in the effort to test for COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:9656-9659.
    PubMed    


    April 2020
  36. FORSTER P, Forster L, Renfrew C, Forster M, et al
    Phylogenetic network analysis of SARS-CoV-2 genomes.
    Proc Natl Acad Sci U S A. 2020;117:9241-9243.
    PubMed     Abstract available


  37. DUAN K, Liu B, Li C, Zhang H, et al
    Effectiveness of convalescent plasma therapy in severe COVID-19 patients.
    Proc Natl Acad Sci U S A. 2020;117:9490-9496.
    PubMed     Abstract available


  38. MOGHADAS SM, Shoukat A, Fitzpatrick MC, Wells CR, et al
    Projecting hospital utilization during the COVID-19 outbreaks in the United States.
    Proc Natl Acad Sci U S A. 2020;117:9122-9126.
    PubMed     Abstract available


    March 2020
  39. WELLS CR, Sah P, Moghadas SM, Pandey A, et al
    Impact of international travel and border control measures on the global spread of the novel 2019 coronavirus outbreak.
    Proc Natl Acad Sci U S A. 2020;117:7504-7509.
    PubMed     Abstract available


  40. MATSUYAMA S, Nao N, Shirato K, Kawase M, et al
    Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells.
    Proc Natl Acad Sci U S A. 2020;117:7001-7003.
    PubMed     Abstract available


  41. PEEPLES L
    News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine.
    Proc Natl Acad Sci U S A. 2020 Mar 30. pii: 2005456117.
    PubMed    


  42. JONES JC, Pascua PNQ, Fabrizio TP, Marathe BM, et al
    Influenza A and B viruses with reduced baloxavir susceptibility display attenuated in vitro fitness but retain ferret transmissibility.
    Proc Natl Acad Sci U S A. 2020 Mar 26. pii: 1916825117.
    PubMed     Abstract available


  43. DE WIT E, Feldmann F, Cronin J, Jordan R, et al
    Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proc Natl Acad Sci U S A. 2020;117:6771-6776.
    PubMed     Abstract available


  44. PABIS A, Rawle RJ, Kasson PM
    Influenza hemagglutinin drives viral entry via two sequential intramembrane mechanisms.
    Proc Natl Acad Sci U S A. 2020 Mar 18. pii: 1914188117.
    PubMed     Abstract available


  45. CHO JH, Zhao B, Shi J, Savage N, et al
    Molecular recognition of a host protein by NS1 of pandemic and seasonal influenza A viruses.
    Proc Natl Acad Sci U S A. 2020 Mar 9. pii: 1920582117.
    PubMed     Abstract available


  46. MARREIROS R, Muller-Schiffmann A, Trossbach SV, Prikulis I, et al
    Disruption of cellular proteostasis by H1N1 influenza A virus causes alpha-synuclein aggregation.
    Proc Natl Acad Sci U S A. 2020 Mar 9. pii: 1906466117.
    PubMed     Abstract available


  47. KLOEPFER KM, Gern JE
    Ecological and individual data both indicate that influenza inhibits rhinovirus infection.
    Proc Natl Acad Sci U S A. 2020 Mar 3. pii: 1922920117.
    PubMed    


  48. NICKBAKHSH S, Mair C, Matthews L, Reeve R, et al
    Reply to Kloepfer and Gern: Independent studies suggest an arms race between influenza and rhinovirus: What next?
    Proc Natl Acad Sci U S A. 2020 Mar 3. pii: 2000903117.
    PubMed    


  49. YANG Q, Zhao X, Lemey P, Suchard MA, et al
    Assessing the role of live poultry trade in community-structured transmission of avian influenza in China.
    Proc Natl Acad Sci U S A. 2020 Mar 2. pii: 1906954117.
    PubMed     Abstract available


    February 2020
  50. TORABIFARD H, Panahi A, Brooks CL 3rd
    M2 amphipathic helices facilitate pH-dependent conformational transition in influenza A virus.
    Proc Natl Acad Sci U S A. 2020 Feb 3. pii: 1913385117.
    PubMed     Abstract available


    January 2020
  51. NEWMAN JH, Chesson CB, Herzog NL, Bommareddy PK, et al
    Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer.
    Proc Natl Acad Sci U S A. 2020;117:1119-1128.
    PubMed     Abstract available


  52. YEH YT, Gulino K, Zhang Y, Sabestien A, et al
    A rapid and label-free platform for virus capture and identification from clinical samples.
    Proc Natl Acad Sci U S A. 2020;117:895-901.
    PubMed     Abstract available


  53. COVES-DATSON EM, King SR, Legendre M, Gupta A, et al
    A molecularly engineered antiviral banana lectin inhibits fusion and is efficacious against influenza virus infection in vivo.
    Proc Natl Acad Sci U S A. 2020 Jan 13. pii: 1915152117.
    PubMed     Abstract available


    December 2019
  54. MCCARTHY KR, Raymond DD, Do KT, Schmidt AG, et al
    Affinity maturation in a human humoral response to influenza hemagglutinin.
    Proc Natl Acad Sci U S A. 2019 Dec 16. pii: 1915620116.
    PubMed     Abstract available


  55. VIRK RK, Jayakumar J, Mendenhall IH, Moorthy M, et al
    Divergent evolutionary trajectories of influenza B viruses underlie their contemporaneous epidemic activity.
    Proc Natl Acad Sci U S A. 2019 Dec 16. pii: 1916585116.
    PubMed     Abstract available


  56. NICKBAKHSH S, Mair C, Matthews L, Reeve R, et al
    Virus-virus interactions impact the population dynamics of influenza and the common cold.
    Proc Natl Acad Sci U S A. 2019 Dec 16. pii: 1911083116.
    PubMed     Abstract available


    October 2019

  57. Correction for Sah et al., Future epidemiological and economic impacts of universal influenza vaccines.
    Proc Natl Acad Sci U S A. 2019 Oct 21. pii: 1917260116.
    PubMed    


  58. BRACHER J
    On the multibin logarithmic score used in the FluSight competitions.
    Proc Natl Acad Sci U S A. 2019;116:20809-20810.
    PubMed    


  59. REICH NG, Osthus D, Ray EL, Yamana TK, et al
    Reply to Bracher: Scoring probabilistic forecasts to maximize public health interpretability.
    Proc Natl Acad Sci U S A. 2019;116:20811-20812.
    PubMed    


  60. POPOVA AV, Safina KR, Ptushenko VV, Stolyarova AV, et al
    Allele-specific nonstationarity in evolution of influenza A virus surface proteins.
    Proc Natl Acad Sci U S A. 2019 Oct 2. pii: 1904246116.
    PubMed     Abstract available


    September 2019
  61. SAH P, Alfaro-Murillo JA, Fitzpatrick MC, Neuzil KM, et al
    Future epidemiological and economic impacts of universal influenza vaccines.
    Proc Natl Acad Sci U S A. 2019 Sep 23. pii: 1909613116.
    PubMed     Abstract available


    August 2019
  62. KENNEY AD, McMichael TM, Imas A, Chesarino NM, et al
    IFITM3 protects the heart during influenza virus infection.
    Proc Natl Acad Sci U S A. 2019 Aug 26. pii: 1900784116.
    PubMed     Abstract available


  63. SCHMIDT N, Domingues P, Golebiowski F, Patzina C, et al
    An influenza virus-triggered SUMO switch orchestrates co-opted endogenous retroviruses to stimulate host antiviral immunity.
    Proc Natl Acad Sci U S A. 2019 Aug 7. pii: 1907031116.
    PubMed     Abstract available


    July 2019
  64. WINARSKI KL, Tang J, Klenow L, Lee J, et al
    Antibody-dependent enhancement of influenza disease promoted by increase in hemagglutinin stem flexibility and virus fusion kinetics.
    Proc Natl Acad Sci U S A. 2019 Jul 11. pii: 1821317116.
    PubMed     Abstract available


    June 2019
  65. LITVINOVA M, Liu QH, Kulikov ES, Ajelli M, et al
    Reactive school closure weakens the network of social interactions and reduces the spread of influenza.
    Proc Natl Acad Sci U S A. 2019 Jun 17. pii: 1821298116.
    PubMed     Abstract available


    May 2019
  66. ZHU B, Zhang R, Li C, Jiang L, et al
    BCL6 modulates tissue neutrophil survival and exacerbates pulmonary inflammation following influenza virus infection.
    Proc Natl Acad Sci U S A. 2019 May 28. pii: 1902310116.
    PubMed     Abstract available


  67. DE GREEF JC, Slutter B, Anderson ME, Hamlyn R, et al
    Protective role for the N-terminal domain of alpha-dystroglycan in Influenza A virus proliferation.
    Proc Natl Acad Sci U S A. 2019 May 16. pii: 1904493116.
    PubMed     Abstract available


  68. KUDO E, Song E, Yockey LJ, Rakib T, et al
    Low ambient humidity impairs barrier function and innate resistance against influenza infection.
    Proc Natl Acad Sci U S A. 2019 May 13. pii: 1902840116.
    PubMed     Abstract available


    April 2019
  69. MASLANKA FIGUEROA S, Veser A, Abstiens K, Fleischmann D, et al
    Influenza A virus mimetic nanoparticles trigger selective cell uptake.
    Proc Natl Acad Sci U S A. 2019 Apr 29. pii: 1902563116.
    PubMed     Abstract available


    February 2019
  70. CULLEN JG, McQuilten HA, Quinn KM, Olshansky M, et al
    CD4(+) T help promotes influenza virus-specific CD8(+) T cell memory by limiting metabolic dysfunction.
    Proc Natl Acad Sci U S A. 2019 Feb 20. pii: 1808849116.
    PubMed     Abstract available


  71. TSENG YC, Wu CY, Liu ML, Chen TH, et al
    Egg-based influenza split virus vaccine with monoglycosylation induces cross-strain protection against influenza virus infections.
    Proc Natl Acad Sci U S A. 2019 Feb 19. pii: 1819197116.
    PubMed     Abstract available


  72. WHITE MC, Tao H, Steel J, Lowen AC, et al
    H5N8 and H7N9 packaging signals constrain HA reassortment with a seasonal H3N2 influenza A virus.
    Proc Natl Acad Sci U S A. 2019 Feb 13. pii: 1818494116.
    PubMed     Abstract available


  73. VIBOUD C, Vespignani A
    The future of influenza forecasts.
    Proc Natl Acad Sci U S A. 2019 Feb 8. pii: 1822167116.
    PubMed    


  74. MORIYAMA M, Ichinohe T
    High ambient temperature dampens adaptive immune responses to influenza A virus infection.
    Proc Natl Acad Sci U S A. 2019 Feb 4. pii: 1815029116.
    PubMed     Abstract available


    January 2019
  75. YAMAUCHI Y
    Quantum dots crack the influenza uncoating puzzle.
    Proc Natl Acad Sci U S A. 2019 Jan 31. pii: 1822089116.
    PubMed    


  76. REICH NG, Brooks LC, Fox SJ, Kandula S, et al
    A collaborative multiyear, multimodel assessment of seasonal influenza forecasting in the United States.
    Proc Natl Acad Sci U S A. 2019 Jan 15. pii: 1812594116.
    PubMed     Abstract available


  77. SEVY AM, Wu NC, Gilchuk IM, Parrish EH, et al
    Multistate design of influenza antibodies improves affinity and breadth against seasonal viruses.
    Proc Natl Acad Sci U S A. 2019 Jan 14. pii: 1806004116.
    PubMed     Abstract available


  78. QIN C, Li W, Li Q, Yin W, et al
    Real-time dissection of dynamic uncoating of individual influenza viruses.
    Proc Natl Acad Sci U S A. 2019 Jan 9. pii: 1812632116.
    PubMed     Abstract available


    December 2018
  79. FURUSE Y
    Analysis of research intensity on infectious disease by disease burden reveals which infectious diseases are neglected by researchers.
    Proc Natl Acad Sci U S A. 2018 Dec 31. pii: 1814484116.
    PubMed     Abstract available


  80. ZHANG K, Shang G, Padavannil A, Wang J, et al
    Structural-functional interactions of NS1-BP protein with the splicing and mRNA export machineries for viral and host gene expression.
    Proc Natl Acad Sci U S A. 2018;115:E12218-E12227.
    PubMed     Abstract available


  81. LUO G, Ambati A, Lin L, Bonvalet M, et al
    Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy.
    Proc Natl Acad Sci U S A. 2018 Dec 12. pii: 1818150116.
    PubMed     Abstract available


  82. LIU QH, Ajelli M, Aleta A, Merler S, et al
    Measurability of the epidemic reproduction number in data-driven contact networks.
    Proc Natl Acad Sci U S A. 2018;115:12680-12685.
    PubMed     Abstract available


    November 2018
  83. FINK AL, Engle K, Ursin RL, Tang WY, et al
    Biological sex affects vaccine efficacy and protection against influenza in mice.
    Proc Natl Acad Sci U S A. 2018 Nov 19. pii: 1805268115.
    PubMed     Abstract available


  84. STEWART-JONES GBE, Chuang GY, Xu K, Zhou T, et al
    Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4.
    Proc Natl Acad Sci U S A. 2018 Nov 12. pii: 1811980115.
    PubMed     Abstract available


    October 2018
  85. GOLDHILL DH, Te Velthuis AJW, Fletcher RA, Langat P, et al
    The mechanism of resistance to favipiravir in influenza.
    Proc Natl Acad Sci U S A. 2018 Oct 23. pii: 1811345115.
    PubMed     Abstract available


    September 2018
  86. BENTON DJ, Nans A, Calder LJ, Turner J, et al
    Influenza hemagglutinin membrane anchor.
    Proc Natl Acad Sci U S A. 2018 Sep 17. pii: 1810927115.
    PubMed     Abstract available


  87. SJAASTAD LE, Fay EJ, Fiege JK, Macchietto MG, et al
    Distinct antiviral signatures revealed by the magnitude and round of influenza virus replication in vivo.
    Proc Natl Acad Sci U S A. 2018 Sep 4. pii: 1807516115.
    PubMed     Abstract available


    August 2018
  88. MADSEN JJ, Grime JMA, Rossman JS, Voth GA, et al
    Entropic forces drive clustering and spatial localization of influenza A M2 during viral budding.
    Proc Natl Acad Sci U S A. 2018 Aug 27. pii: 1805443115.
    PubMed     Abstract available


  89. LEE JM, Huddleston J, Doud MB, Hooper KA, et al
    Deep mutational scanning of hemagglutinin helps predict evolutionary fates of human H3N2 influenza variants.
    Proc Natl Acad Sci U S A. 2018 Aug 13. pii: 1806133115.
    PubMed     Abstract available


    July 2018
  90. DENG L, Chang TZ, Wang Y, Li S, et al
    Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in mice.
    Proc Natl Acad Sci U S A. 2018 Jul 31. pii: 1805713115.
    PubMed     Abstract available


  91. GUALDONI GA, Mayer KA, Kapsch AM, Kreuzberg K, et al
    Rhinovirus induces an anabolic reprogramming in host cell metabolism essential for viral replication.
    Proc Natl Acad Sci U S A. 2018;115:E7158-E7165.
    PubMed     Abstract available


  92. LIN X, Noel JK, Wang Q, Ma J, et al
    Atomistic simulations indicate the functional loop-to-coiled-coil transition in influenza hemagglutinin is not downhill.
    Proc Natl Acad Sci U S A. 2018 Jul 16. pii: 1805442115.
    PubMed     Abstract available


    June 2018
  93. UEKI H, Wang IH, Fukuyama S, Katsura H, et al
    In vivo imaging of the pathophysiological changes and neutrophil dynamics in influenza virus-infected mouse lungs.
    Proc Natl Acad Sci U S A. 2018 Jun 25. pii: 1806265115.
    PubMed     Abstract available


  94. ZHOU J, Li C, Sachs N, Chiu MC, et al
    Differentiated human airway organoids to assess infectivity of emerging influenza virus.
    Proc Natl Acad Sci U S A. 2018 Jun 11. pii: 1806308115.
    PubMed     Abstract available


    April 2018
  95. SAH P, Medlock J, Fitzpatrick MC, Singer BH, et al
    Optimizing the impact of low-efficacy influenza vaccines.
    Proc Natl Acad Sci U S A. 2018 Apr 30. pii: 1802479115.
    PubMed     Abstract available


  96. KADAM RU, Wilson IA
    A small-molecule fragment that emulates binding of receptor and broadly neutralizing antibodies to influenza A hemagglutinin.
    Proc Natl Acad Sci U S A. 2018 Apr 2. pii: 1801999115.
    PubMed     Abstract available


    February 2018
  97. PEI S, Kandula S, Yang W, Shaman J, et al
    Forecasting the spatial transmission of influenza in the United States.
    Proc Natl Acad Sci U S A. 2018 Feb 26. pii: 1708856115.
    PubMed     Abstract available


  98. ZHOU J, Wei J, Choy KT, Sia SF, et al
    Defining the sizes of airborne particles that mediate influenza transmission in ferrets.
    Proc Natl Acad Sci U S A. 2018 Feb 20. pii: 1716771115.
    PubMed     Abstract available


    January 2018
  99. YAN J, Grantham M, Pantelic J, Bueno de Mesquita PJ, et al
    Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community.
    Proc Natl Acad Sci U S A. 2018 Jan 18. pii: 1716561115.
    PubMed     Abstract available


  100. MENACHERY VD, Schafer A, Burnum-Johnson KE, Mitchell HD, et al
    MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape.
    Proc Natl Acad Sci U S A. 2018 Jan 16. pii: 1706928115.
    PubMed     Abstract available


    December 2017
  101. RAYMOND DD, Bajic G, Ferdman J, Suphaphiphat P, et al
    Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody.
    Proc Natl Acad Sci U S A. 2017 Dec 18. pii: 1715471115.
    PubMed     Abstract available


    November 2017
  102. ELKINS MR, Williams JK, Gelenter MD, Dai P, et al
    Cholesterol-binding site of the influenza M2 protein in lipid bilayers from solid-state NMR.
    Proc Natl Acad Sci U S A. 2017 Nov 20. pii: 201715127.
    PubMed     Abstract available


  103. ZOST SJ, Parkhouse K, Gumina ME, Kim K, et al
    Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.
    Proc Natl Acad Sci U S A. 2017 Nov 6. pii: 201712377.
    PubMed     Abstract available


    September 2017
  104. ZANIN M, Wong SS, Barman S, Kaewborisuth C, et al
    Molecular basis of mammalian transmissibility of avian H1N1 influenza viruses and their pandemic potential.
    Proc Natl Acad Sci U S A. 2017 Sep 5. pii: 201713974.
    PubMed     Abstract available


  105. MAAMARY J, Wang TT, Tan GS, Palese P, et al
    Increasing the breadth and potency of response to the seasonal influenza virus vaccine by immune complex immunization.
    Proc Natl Acad Sci U S A. 2017 Sep 5. pii: 201707950.
    PubMed     Abstract available


    August 2017
  106. THOMASTON JL, Woldeyes RA, Nakane T, Yamashita A, et al
    XFEL structures of the influenza M2 proton channel: Room temperature water networks and insights into proton conduction.
    Proc Natl Acad Sci U S A. 2017 Aug 23. pii: 201705624.
    PubMed     Abstract available


    July 2017
  107. NIKOLAIDIS NM, Noel JG, Pitstick LB, Gardner JC, et al
    Mitogenic stimulation accelerates influenza-induced mortality by increasing susceptibility of alveolar type II cells to infection.
    Proc Natl Acad Sci U S A. 2017 Jul 24. pii: 201621172.
    PubMed     Abstract available


  108. ASGARI S, Schlapbach LJ, Anchisi S, Hammer C, et al
    Severe viral respiratory infections in children with IFIH1 loss-of-function mutations.
    Proc Natl Acad Sci U S A. 2017 Jul 17. pii: 201704259.
    PubMed     Abstract available


  109. BLACKMORE S, Hernandez J, Juda M, Ryder E, et al
    Influenza infection triggers disease in a genetic model of experimental autoimmune encephalomyelitis.
    Proc Natl Acad Sci U S A. 2017 Jul 10. pii: 201620415.
    PubMed     Abstract available


    May 2017
  110. PIZZOLLA A, Wang Z, Groom JR, Kedzierska K, et al
    Nasal-associated lymphoid tissues (NALTs) support the recall but not priming of influenza virus-specific cytotoxic T cells.
    Proc Natl Acad Sci U S A. 2017 May 1. pii: 201620194.
    PubMed     Abstract available


    April 2017
  111. XIE J, Sok D, Wu NC, Zheng T, et al
    Immunochemical engineering of cell surfaces to generate virus resistance.
    Proc Natl Acad Sci U S A. 2017 Apr 10. pii: 201702764.
    PubMed     Abstract available


  112. SHANKS GD, Brundage JF
    Variable mortality during the 1918 influenza pandemic in Chicago.
    Proc Natl Acad Sci U S A. 2017 Apr 6. pii: 201701344.
    PubMed    


    March 2017
  113. BASKERVILLE EB, Cobey S
    Does influenza drive absolute humidity?
    Proc Natl Acad Sci U S A. 2017 Mar 15. pii: 201700369.
    PubMed    


    February 2017
  114. KREMENTSOV DN, Case LK, Dienz O, Raza A, et al
    Genetic variation in chromosome Y regulates susceptibility to influenza A virus infection.
    Proc Natl Acad Sci U S A. 2017 Feb 27. pii: 201620889.
    PubMed     Abstract available


    December 2016
  115. WU CY, Lin CW, Tsai TI, Lee CD, et al
    Influenza A surface glycosylation and vaccine design.
    Proc Natl Acad Sci U S A. 2016 Dec 27. pii: 201617174.
    PubMed     Abstract available


  116. KADAM RU, Wilson IA
    Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol.
    Proc Natl Acad Sci U S A. 2016 Dec 21. pii: 201617020.
    PubMed     Abstract available


  117. PING J, Lopes TJ, Neumann G, Kawaoka Y, et al
    Development of high-yield influenza B virus vaccine viruses.
    Proc Natl Acad Sci U S A. 2016 Dec 5. pii: 201616530.
    PubMed     Abstract available


    November 2016
  118. CHOWELL G, Viboud C
    Pandemic influenza and socioeconomic disparities: Lessons from 1918 Chicago.
    Proc Natl Acad Sci U S A. 2016;113:13557-13559.
    PubMed    


  119. GRANTZ KH, Rane MS, Salje H, Glass GE, et al
    Disparities in influenza mortality and transmission related to sociodemographic factors within Chicago in the pandemic of 1918.
    Proc Natl Acad Sci U S A. 2016 Nov 21. pii: 201612838.
    PubMed     Abstract available


  120. BJORNSTAD ON, Viboud C
    Timing and periodicity of influenza epidemics.
    Proc Natl Acad Sci U S A. 2016 Nov 3. pii: 201616052.
    PubMed    


    October 2016
  121. DEYLE ER, Maher MC, Hernandez RD, Basu S, et al
    Global environmental drivers of influenza.
    Proc Natl Acad Sci U S A. 2016 Oct 31. pii: 201607747.
    PubMed     Abstract available


  122. YAMIN D, Jones FK, DeVincenzo JP, Gertler S, et al
    Vaccination strategies against respiratory syncytial virus.
    Proc Natl Acad Sci U S A. 2016 Oct 31. pii: 201522597.
    PubMed     Abstract available


  123. RAMEY AM, Spackman E, Kim-Torchetti M, DeLiberto TJ, et al
    Weak support for disappearance and restricted emergence/persistence of highly pathogenic influenza A in North American waterfowl.
    Proc Natl Acad Sci U S A. 2016;113:E6551-E6552.
    PubMed    


  124. LIANG R, Swanson JM, Madsen JJ, Hong M, et al
    Acid activation mechanism of the influenza A M2 proton channel.
    Proc Natl Acad Sci U S A. 2016 Oct 24. pii: 201615471.
    PubMed     Abstract available


  125. MOREIRA EA, Locher S, Kolesnikova L, Bolte H, et al
    Synthetically derived bat influenza A-like viruses reveal a cell type- but not species-specific tropism.
    Proc Natl Acad Sci U S A. 2016 Oct 24. pii: 201608821.
    PubMed     Abstract available


  126. HE W, Tan GS, Mullarkey CE, Lee AJ, et al
    Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus.
    Proc Natl Acad Sci U S A. 2016 Oct 3. pii: 201609316.
    PubMed     Abstract available


    September 2016
  127. LEON PE, He W, Mullarkey CE, Bailey MJ, et al
    Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact.
    Proc Natl Acad Sci U S A. 2016 Sep 19. pii: 201613225.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: